As people age, a buildup of calcium on the aortic valve can make it thicker and stiffer leading to aortic stenosis.

Early surgical or transcatheter aortic valve replacement is not typically recommended for severe aortic stenosis in the ...

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

The following is a summary of "Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ...

TAVR stands for Transcatheter Aortic Valve Replacement. The heart has four valves that makes sure the blood goes in the right ...

The following is a summary of "Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated ...

the largest international head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR). In patients with aortic stenosis and a small aortic annulus, results showed ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...

At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.